0622 Remote Patient Monitoring to Manage OSA Using a Variety of Therapeutic Approaches in an Active Sleep Practice

Abstract Introduction Remote Patient Monitoring (RPM) using the REST-Tracker system incorporates FDA cleared SleepImage OSA analysis from a ring oximeter worn nightly providing output metrics corresponding to the AASMs 1A/1B Hypopnea rules (sAHI3%/sAHI4% respectively). The REST-Tracker system assists in improving clinical decisions, reducing treatment failures and lowering the burden of repeated (in-lab/home) OSA sleep testing. Other systems currently in use for OSA management rely on PAP derived indexes, loosely labeled as an AHI equivalent, and are falsely considered by many as equivalent to FDA cleared HSAT derived metrics. Such systems only provide data while using PAP devices and have no utility with other treatment approaches such as Inspire or OAT. Our OSA patients are treated via a variety of therapeutic approaches and we provide here a summarization of our current experience using this new REST-Tracker approach and an additional PAP-subanalysis to assess the sensitivity of the PAP derived AHI metric (pAHI) metric which is used by other RPM systems. Methods OSA patients undergoing treatments ranging from PAP, OAT, Inspire, surgery, or in-combination were monitored nightly with the REST-Tracker ring RPM platform. The sAHI3%/sAHI4% output metrics were managed by staff using REST-Tracker and therapy adjusted in accordance with patients' circumstances, optimizing treatment. PAP-subanalysis: A subset of 10 PAP patients data was extracted to compare the pAHI metric to the corresponding sAHIs(3%&4%). Results 95 patients monitored, ranging 6-28 months, across all treatment groups (39-PAP, 14-Inspire, 7-OAT, 9-combo-PAP-OAT, 16-combo-Inspire-PAP and 10-Combo-MMA-Inspire/other), with an average Diagnostic 1A AHI=30.4(+/-21.0)/1B AHI=15.65(+/-17.8) improved with most recent 30-day data demonstrating average sAHI3%=11.5(+/- 8.0) sAHI4%=6.3(+/-5.6). For the PAP-subanalysis, duration ranged/per patient from 120-284 nights, Median values of pAHI=2.6, sAHI3%=10.4 & sAHI4%=3.4 Conclusion The REST-Tracker provides longitudinal nightly assessment giving clinicians objective measures to assist treatment decisions and is superior to single-night testing and agnostic to treatment approaches, unlike other PAP-dependant RPM systems. A more elaborate detailed presentation with clinical examples will be presented at the conference, demonstrating this futuristic approach in sleep health disease management. Support (if any)